These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection. Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380 [TBL] [Abstract][Full Text] [Related]
3. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds. Errami A; Baghdadi JE; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Rada N; Benajiba N; Mokhantar K; Ouazahrou K; Zaidi S; Abel L; Casanova JL; Boisson-Dupuis S; Bustamante J; Bousfiha AA J Clin Immunol; 2023 May; 43(4):728-740. PubMed ID: 36630059 [TBL] [Abstract][Full Text] [Related]
4. Severe BCG-osis Misdiagnosed as Multidrug-Resistant Tuberculosis in an IL-12Rβ1-Deficient Peruvian Girl. Esteve-Sole A; Sánchez-Dávila SP; Deyà-Martínez A; Freeman AF; Zelazny AM; Dekker JP; Khil PP; Holland SM; Noguera-Julian A; Bustamante J; Casanova JL; Juan M; Cordova W; Alsina L J Clin Immunol; 2018 Aug; 38(6):712-716. PubMed ID: 30039354 [TBL] [Abstract][Full Text] [Related]
5. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease. Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640 [TBL] [Abstract][Full Text] [Related]
6. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients. Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053 [TBL] [Abstract][Full Text] [Related]
7. Mendelian susceptibility to mycobacterial diseases: state of the art. Noma K; Mizoguchi Y; Tsumura M; Okada S Clin Microbiol Infect; 2022 Nov; 28(11):1429-1434. PubMed ID: 35283318 [TBL] [Abstract][Full Text] [Related]
8. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease. Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa. van Coller A; Glanzmann B; Cornelissen H; Möller M; Kinnear C; Esser M; Glashoff R BMC Immunol; 2021 Sep; 22(1):62. PubMed ID: 34517836 [TBL] [Abstract][Full Text] [Related]
10. Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ. Tsumura M; Miki M; Mizoguchi Y; Hirata O; Nishimura S; Tamaura M; Kagawa R; Hayakawa S; Kobayashi M; Okada S J Allergy Clin Immunol; 2022 Jan; 149(1):252-261.e6. PubMed ID: 34176646 [TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological profile of children with Mendelian Susceptibility to Mycobacterial Diseases (MSMD) from an Indian tertiary care hospital. Indumathi CK; Bustamante J Indian J Tuberc; 2021 Apr; 68(2):292-297. PubMed ID: 33845970 [TBL] [Abstract][Full Text] [Related]
12. IL-12Rβ1 deficiency corresponding to concurrency of two diseases, mendelian susceptibility to mycobacterial disease and Crohn's disease. Khoshnevisan R; Nekooei-Marnany N; Klein C; Kotlarz D; Behnam M; Ostadi V; Yaran M; Rezaei A; Sherkat R J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100123. PubMed ID: 31788565 [TBL] [Abstract][Full Text] [Related]
13. Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China. Ying W; Liu D; Dong X; Wang W; Hui X; Hou J; Yao H; Zhou Q; Sun B; Sun J; Wang X J Clin Immunol; 2019 Aug; 39(6):600-610. PubMed ID: 31367980 [TBL] [Abstract][Full Text] [Related]
14. Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases. Wang LH; Yen CL; Chang TC; Liu CC; Shieh CC J Microbiol Immunol Infect; 2012 Dec; 45(6):411-7. PubMed ID: 23036270 [TBL] [Abstract][Full Text] [Related]
15. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Bustamante J; Boisson-Dupuis S; Abel L; Casanova JL Semin Immunol; 2014 Dec; 26(6):454-70. PubMed ID: 25453225 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India. Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM Front Immunol; 2021; 12():631298. PubMed ID: 33732252 [TBL] [Abstract][Full Text] [Related]
18. Novel Mutation of Interferon-γ Receptor 1 Gene Presenting as Early Life Mycobacterial Bronchial Disease. Gutierrez MJ; Kalra N; Horwitz A; Nino G J Investig Med High Impact Case Rep; 2016; 4(4):2324709616675463. PubMed ID: 27868075 [TBL] [Abstract][Full Text] [Related]
19. A Novel Homozygous Stop Mutation in IL23R Causes Mendelian Susceptibility to Mycobacterial Disease. Staels F; Lorenzetti F; De Keukeleere K; Willemsen M; Gerbaux M; Neumann J; Tousseyn T; Pasciuto E; De Munter P; Bossuyt X; Gijsbers R; Liston A; Humblet-Baron S; Schrijvers R J Clin Immunol; 2022 Nov; 42(8):1638-1652. PubMed ID: 35829840 [TBL] [Abstract][Full Text] [Related]
20. Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review. Khavandegar A; Mahdaviani SA; Zaki-Dizaji M; Khalili-Moghaddam F; Ansari S; Alijani S; Taherzadeh-Ghahfarrokhi N; Mansouri D; Casanova JL; Bustamante J; Jamee M J Allergy Clin Immunol; 2024 May; 153(5):1432-1444. PubMed ID: 38341181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]